Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Giulia Mosconi

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Neurology|April 13, 2026
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial FibrillationMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|December 21, 2018
Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and OutcomesMaurizio Paciaroni, Fabio Bandini, Giancarlo Agnelli, et al.
Stroke|March 4, 2021
Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke PreventionMaurizio Paciaroni, Giancarlo Agnelli, Michela Giustozzi, et al.
Stroke|May 11, 2022
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND StudyMaurizio Paciaroni, Valeria Caso, Giancarlo Agnelli, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Neurology|April 13, 2026
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial FibrillationMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|December 21, 2018
Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and OutcomesMaurizio Paciaroni, Fabio Bandini, Giancarlo Agnelli, et al.
Stroke|March 4, 2021
Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke PreventionMaurizio Paciaroni, Giancarlo Agnelli, Michela Giustozzi, et al.
Stroke|May 11, 2022
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND StudyMaurizio Paciaroni, Valeria Caso, Giancarlo Agnelli, et al.
Pageof 6